Modern Approaches for Enhancing Drug Solubility: An Overview of Technologies

Solubility refers to the ability of a solute to dissolve in a solvent under specific conditions of pressure and temperature to form a uniform solution. However, many active pharmaceutical ingredients (APIs) are poorly water-soluble or hydrophobic, making solubility one of the most challenging factors in drug formulation development. Low aqueous solubility often leads to reduced bioavailability, limiting the drug’s therapeutic potential and overall product performance. Therefore, enhancing solubility is essential to ensure optimal drug absorption and efficacy. Many promising drug candidates fail to progress in development due to poor solubility, despite having high pharmacological activity. To address this issue, various solubility enhancement strategies are employed. These include chemical modifications such as salt formation and co-crystallization; physical approaches like polymorph and habit modification; complexation techniques including physical mixtures and inclusion complexes; surfactant-based methods like self-emulsifying drug delivery systems (SEDDS); solid dispersion techniques; pH adjustment; and advanced technologies like liquisolid systems, supercritical fluid processing, and polymer-based modifications. This article aims to consolidate and apply multiple solubility enhancement techniques to improve the aqueous solubility and therapeutic performance of poorly water-soluble drugs.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-07-04
DOI
https://doi.org/10.5281/zenodo.15806349
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Modern Approaches for Enhancing Drug Solubility: An Overview of Technologies

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

Modern Approaches for Enhancing Drug Solubility: An Overview of Technologies

article en

Abstract

Solubility refers to the ability of a solute to dissolve in a solvent under specific conditions of pressure and temperature to form a uniform solution. However, many active pharmaceutical ingredients (APIs) are poorly water-soluble or hydrophobic, making solubility one of the most challenging factors in drug formulation development. Low aqueous solubility often leads to reduced bioavailability, limiting the drug’s therapeutic potential and overall product performance. Therefore, enhancing solubility is essential to ensure optimal drug absorption and efficacy. Many promising drug candidates fail to progress in development due to poor solubility, despite having high pharmacological activity. To address this issue, various solubility enhancement strategies are employed. These include chemical modifications such as salt formation and co-crystallization; physical approaches like polymorph and habit modification; complexation techniques including physical mixtures and inclusion complexes; surfactant-based methods like self-emulsifying drug delivery systems (SEDDS); solid dispersion techniques; pH adjustment; and advanced technologies like liquisolid systems, supercritical fluid processing, and polymer-based modifications. This article aims to consolidate and apply multiple solubility enhancement techniques to improve the aqueous solubility and therapeutic performance of poorly water-soluble drugs.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 65%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.